Quantum Labs
Português (Brasil)
PT-141 10 mgPack de 10 frascos6 em estoqueEconomize 25%
peptideintermediate6 em estoque

PT-141 10 mg

Agonista da melanocortina bremelanotida

PT-141 bremelanotide research peptide, Australian-shipped. Lab-verified ≥99% purity.

Dose
10mg / frasco
Forma
Pó liofilizado
Pack
Pack de 10 frascos

Somente para uso em pesquisa. Este composto é vendido estritamente para pesquisa in vitro e fins laboratoriais e não se destina ao consumo humano nem a uso terapêutico. Ao comprar, você confirma que é um pesquisador qualificado e concorda com o nosso aviso legal completo.

R$ 744 BRL
Economize 25%
Pack de 10 frascos
De R$ 990 BRL
Vendido em pack de 10 frascos

Restam apenas 6 packs

🧪Verificado em laboratório
✓Analisado por terceiros
⚡Envio mundial rápido
🔒Pagamento seguro com cartão
Visão geral

Agonista sintético dos receptores da melanocortina, estudado pelos efeitos sobre as vias neurais associadas à resposta sexual em aplicações de pesquisa.

PT-141 (bremelanotide) is a synthetic melanocortin-receptor agonist derived from the alpha-melanocyte-stimulating hormone (α-MSH) family. It is one of the most studied melanocortin-pathway research peptides outside of the tanning-active analogues. Quantum Labs supplies PT-141 as a lyophilised powder for Australian research applications.

Research on PT-141 has covered the central melanocortin pathway, particularly MC3R and MC4R receptor activation, and pre-clinical models of sexual-response signalling. Material is HPLC-verified to ≥99% purity and ships from Australian stock; supplied for laboratory research use only.

Mecanismo

A pesquisa sugere agonismo primário de MC4R, com efeitos no sistema nervoso central sobre marcadores neuroquímicos em sujeitos de estudo.

Relatório laboratorial

Verificado por HPLC em relação a uma especificação de pureza ≥99 %. Testado de forma independente por laboratórios terceiros credenciados.

FAQ para investigadores

PT-141 — perguntas frequentes

What is PT-141?

PT-141 (bremelanotide) is a synthetic melanocortin-receptor agonist studied in research models of central melanocortin-pathway signalling. It is one of the most-studied research peptides in the melanocortin family alongside the tanning-active analogues.

Is PT-141 legal in Australia?

PT-141 is restricted for compounded human therapeutic supply in Australia and remains available for research and laboratory use when supplied without therapeutic representation. Quantum Labs supplies PT-141 for research use only.

What receptors does PT-141 target?

PT-141 primarily activates the melanocortin-3 (MC3R) and melanocortin-4 (MC4R) receptors. Research has focused on the central melanocortin pathway, particularly downstream signalling in MC4R-rich brain regions.

What is bremelanotide?

Bremelanotide is the generic name for PT-141. It is a cyclic synthetic peptide derived from the α-MSH lineage. PT-141 is the research-code designation; bremelanotide is the pharmaceutical name.

What is the typical PT-141 research dosage?

Published research protocols have used wide dose ranges depending on the model and delivery route (intranasal, subcutaneous). Human dosing is not established. Researchers should consult primary literature for protocol-specific guidance.

Leituras adicionais

Guias relacionados com PT-141

Compostos relacionados

Os investigadores também exploram